Internal Medicine

 

Vishal Pall, MD

 
Assistant Clinical Professorr of Medicine, UCSF

 

  Medical School: Government Medical College, India
  Residency: University of Texas Medical Branch
  Board Certified: Internal Medicine
General Preventive Medicine and Public Health
  Awards and Recognition: Distinction in Clinical Pharmacology Award
Darshi Gupta Scholarship
Best Resident Award
  Publications:  
   
  1. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Internal Medicine Vol I, 3rd Edition. ©2002 by Blackwell Science, Inc.
  2. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Internal Medicine Vol II, 3rd Edition. ©2002 by Blackwell Science, Inc.
  3. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Surgery, 3rd Edition. ©2005 by Blackwell Science, Inc.
  4. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Emergency Medicine, 3rd Edition. ©2005 by Blackwell Science, Inc.
  5. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Neurology, 3rd Edition. ©2005 by Blackwell Science, Inc.
  6. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Obstetrics and Gynecology, 3rd Edition. ©2005 by Blackwell Science, Inc.
  7. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Psychiatry, 3rd Edition. ©2005 by Blackwell Science, Inc.
  8. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Pediatrics, 3rd Edition. ©2005 by Blackwell Science, Inc.
  9. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Anatomy, 4th Edition. ©2005 by Blackwell Science, Inc.
  10. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Behavioral Science, 4th Edition. ©2005 by Blackwell Science, Inc.
  11. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Pharmacology, 4th Edition. ©2005 by Blackwell Science, Inc.
  12. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Biochemistry, 4th Edition. ©2005 by Blackwell Science, Inc.
  13. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Microbiology Vol I, 4th Edition. ©2005 by Blackwell Science, Inc.
  14. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Microbiology Vol II, 4th Edition. ©2005 by Blackwell Science, Inc.
  15. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Pathophysiology Vol I, 4th Edition. ©2005 by Blackwell Science, Inc.
  16. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Pathophysiology Vol II, 4th Edition. ©2005 by Blackwell Science, Inc.
  17. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Pathophysiology Vol III, 4th Edition. ©2005 by Blackwell Science, Inc.
  18. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Basic Science Color Atlas. ©2005 by Blackwell Science, Inc.
  19. Series Editor and Author V. Pall, et al. Blackwell’s Underground Clinical Vignettes – Clinical Science Color Atlas. ©2005 by Blackwell Science, Inc.
  20. V. Pall, et al. Use of Ribavirin for treatment of Viral Hemorrhagic Fever in the context of Bioterrorism, Capstone Project, submitted to the faculty at Graduate School of Biomedical Sciences at UTMB, Galveston. ©2004.

  1. V. Pall, et al. Use of Ribavirin for treatment of Viral Hemorrhagic Fever in the context of Bioterrorism, Capstone Project, submitted to the faculty at Graduate School of Biomedical Sciences at UTMB, Galveston. ©2004
  2. Huang, Pall et al. The favorable Effect of Alpha 1 Receptor Blockers on Lipid profile in men older than 55. Journal of Investigative Medicine Jan 2009; 1-Vol 57-Pg124.
  3. Gu, Pall et al. The lipid and weight change associated with beta-blocker in type 2 diabetes. Journal of Investigative Medicine Jan 2009; 1-Vol 57-Pg111.
  4. Gu, Pall et al. Beta-blocker, calcium channel blocker, and statin affect EGFR in patients with type 2 diabetes. Journal of Investigative Medicine Jan 2009; 1-Vol 57-Pg205